Venous thromboembolic disease and hematologic considerations in obesity.
Venous thromboembolic disease continues to be a major source of morbidity and mortality, with obese patients who are critically ill presenting some of the most at-risk patients. As the literature evolves, it has become clear that there is a complex relationship between obesity and thrombosis and atherogenesis. It is true that many of these conditions are reversible with weight loss; however, obesity remains on the rise. Management of obese patients must incorporate and consider these intricate changes in an attempt to improve patient outcomes.
Craft
Mitchell K
MK
Division of Critical Care Medicine, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA 17822, USA.
Reed
Mary Jane
MJ
D016638:Critical Illness; D006801:Humans; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology*; D011655:Pulmonary Embolism / Q000150:complications* / Q000503:physiopathology; D054556:Venous Thromboembolism / Q000150:complications* / Q000503:physiopathology; D020246:Venous Thrombosis / Q000150:complications*